Robert Melo M.D., CCH was raised in a family with a history in homeopathy, where his father, uncle, and elder brother were all M.D.s. with post graduate studies in homeopathy. He is a medical doctor trained in conventional medicine at Xavier University in Bogota and University of Miami (Jackson Memorial Hospital). After medical school, he did studies in Acupuncture and Neural Therapy in Colombia and completed studies in homeopathy at The Royal London Homeopathic Hospital, where he also got involved in a research program lead by Dr Peter Fisher (Director of Research at The Royal London Homeopathic Hospital) and Dr Flavio Dantas (Prof of homeopathy at University of Uberlandia from Brazil).

Robert is currently President of OHM pharma inc., an appointed member of the HPCUS (Homeopathic Pharmacopoeia Convention of the United States, the organization that maintains the policies and procedures of the official compendium of homeopathy manufacturing in the USA), and is a current member of the American Association of Homeopathic Pharmacists, American Institute of Homeopathy, Liga Medicorum Homoeopathica Internationalis, North American Society of Homeopaths, and National Center for Homeopathy.

Robert is passionate about helping professional homeopaths expand the practice of homeopathy, integrating our community of homeopaths (emphasizing respect and acceptance of different schools of thought), integrating homeopathy into mainstream medicine, and supporting research into scientific methodology that can validate the effectiveness of homeopathy.